{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:49Z","timestamp":1790700589524,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003151","name":"Quebec Research Fund Nature and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.radonc.2020.01.017","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T06:19:05Z","timestamp":1581056345000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT"],"prefix":"10.1016","volume":"144","author":[{"given":"Andr\u00e9","family":"Diamant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veng Jean","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishek","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Bahig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Doucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Khosrow-Khavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam El","family":"Naqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Seuntjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.01.017_b0005","unstructured":"Canadian Cancer Society, What is non-small cell lung cancer?; 2015. URL:http:\/\/www.cancer.org\/cancer\/lungcancer-non-smallcell\/detailedguide\/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer."},{"key":"10.1016\/j.radonc.2020.01.017_b0010","unstructured":"N.C. Institute. Metastatic Cancer Fact Sheet \u2013 National Cancer Institute; 2016. URL:https:\/\/www.cancer.gov\/types\/metastatic-cancer."},{"key":"10.1016\/j.radonc.2020.01.017_b0015","doi-asserted-by":"crossref","unstructured":"Diamant A, Chatterjee A, Faria S, Naqa I, Bahig H, Filion E, Robinson C, Al-Halabi H, Seuntjens J. Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?. Radiother Oncol 2018;128(3):513\u201319. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.012.","DOI":"10.1016\/j.radonc.2018.05.012"},{"key":"10.1016\/j.radonc.2020.01.017_b0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2016.01.051","article-title":"CTV: the third front","volume":"95","author":"Kim","year":"2016","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","article-title":"Errors and margins in radiotherapy","volume":"14","author":"Van Herk","year":"2004","journal-title":"Semin Rad Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0030","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ejcts.2007.02.021","article-title":"Immunohistochemistry-detected microscopic tumor spread affects outcome in en-bloc resection for T3-chest wall lung cancer","volume":"31","author":"Mineo","year":"2007","journal-title":"Eur J Cardio-thoracic Surg"},{"key":"10.1016\/j.radonc.2020.01.017_b0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2010.09.001","article-title":"Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features","volume":"82","author":"Van Loon","year":"2012","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2013.08.028","article-title":"Microscopic disease extensions as a risk factor for loco-regional recurrence of NSCLC after SBRT","volume":"109","author":"Salguero","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0045","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2010.10.064","article-title":"Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer","volume":"82","author":"Meng","year":"2012","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/153303461000900502","article-title":"The CyberKnife\u00ae robotic radiosurgery system in 2010","volume":"9","author":"Kilby","year":"2010","journal-title":"Technol Cancer Res Treatment"},{"key":"10.1016\/j.radonc.2020.01.017_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jrr\/rru092","article-title":"Treatment outcomes using CyberKnife for brain metastases from lung cancer","volume":"56","author":"Tamari","year":"2015","journal-title":"J Rad Res"},{"key":"10.1016\/j.radonc.2020.01.017_b0060","series-title":"CyberKnife radiosurgery for stage I lung cancer: results at 36 months","author":"Brown","year":"2007"},{"key":"10.1016\/j.radonc.2020.01.017_b0065","first-page":"407","article-title":"Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastases","volume":"7","author":"Wang","year":"2015","journal-title":"J Thoracic Disease"},{"key":"10.1016\/j.radonc.2020.01.017_b0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLC.2008.n.032","article-title":"Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography\/computed tomography-based treatment planning","volume":"9","author":"Coon","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2020.01.017_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1748-717X-2-39","article-title":"Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors","volume":"2","author":"Collins","year":"2007","journal-title":"Rad Oncol (London, England)"},{"key":"10.1016\/j.radonc.2020.01.017_b0080","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","article-title":"A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927)","volume":"93","author":"Videtic","year":"2015","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2009.08.001","article-title":"Comparison of planned dose distributions calculated by monte carlo and ray-trace algorithms for the treatment of lung tumors with CyberKnife: a preliminary study in 33 patients","volume":"77","author":"Wilcox","year":"2010","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1120\/jacmp.v14i5.4280","article-title":"Evaluation of the influence of tumor location and size on the difference of dose calculation between Ray Tracing algorithm and Fast Monte Carlo algorithm in stereotactic body radiotherapy of non-small cell lung cancer using CyberKnife","volume":"14","author":"Wu","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0100","first-page":"67","article-title":"Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers","volume":"3","author":"Braunstein","year":"2014","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.radonc.2020.01.017_b0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmir.2011.09.002","article-title":"Evaluation of the AAA treatment planning algorithm for SBRT lung treatment: comparison with monte carlo and homogeneous pencil beam dose calculations","volume":"43","author":"Gete","year":"2012","journal-title":"J Med Imag Rad Sci"},{"key":"10.1016\/j.radonc.2020.01.017_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1120\/jacmp.v15i2.4662","article-title":"Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions","volume":"15","author":"Ojala","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.01.017_b0115","doi-asserted-by":"crossref","unstructured":"Tsuruta Y, Nakata M, Nakamura M, Matsuo Y, Higashimura K, Monzen H, Mizowaki T, Hiraoka M. Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer. Med Phys 41(8).https:\/\/doi.org\/10.1118\/1.4890592.","DOI":"10.1118\/1.4890592"},{"key":"10.1016\/j.radonc.2020.01.017_b0120","doi-asserted-by":"crossref","unstructured":"Huang B, Wu L, Lin P, Chen C. Dose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy treatment with flattening filter free beams and the potential role of calculation grid size. Rad Oncol 10(1).https:\/\/doi.org\/10.1186\/s13014-015-0357-0.","DOI":"10.1186\/s13014-015-0357-0"},{"key":"10.1016\/j.radonc.2020.01.017_b0125","first-page":"2001","article-title":"The EGSnrc code system: monte carlo simulation of electron and photon transport","author":"Kawrakow","year":"2016","journal-title":"NRCC Report"},{"key":"10.1016\/j.radonc.2020.01.017_b0130","series-title":"Large-scale dosimetric assessment of Monte Carlo recalculated doses for lung robotic stereotactic body radiation therapy","author":"Heng","year":"2019"},{"key":"10.1016\/j.radonc.2020.01.017_b0135","series-title":"Stereotactic body radiation therapy","author":"Chang","year":"2005"},{"key":"10.1016\/j.radonc.2020.01.017_b0140","series-title":"Radiobiology for the radiologist","author":"Hall","year":"2012"},{"key":"10.1016\/j.radonc.2020.01.017_b0145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Brit J Radiol"},{"key":"10.1016\/j.radonc.2020.01.017_b0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2012.10.006","article-title":"Bioeffect modeling and equieffective dose concepts in radiation oncology-Terminology, quantities and units","volume":"105","author":"Bentzen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.radonc.2020.01.017_b0160","unstructured":"Davidson-Pilon C, Kalderstam J, Zivich P, Kuhn B, Fiore-Gartland A, Moneda L, Gabriel, WIlson D, Parij A, Stark K, Anton S, Besson L, Jona, Gadgil H, Golland D, Hussey S, Kumar R, Noorbakhsh J, Klintberg A, Ochoa E, Albrecht D, Dhuynh, Medvinsky D, Zgonjanin D, Katz DS, Chen D, Ahern C, Fournier C, Arturo, Rendeiro AF. CamDavidsonPilon\/lifelines: v0.22.3 (late) (aug 2019).https:\/\/doi.org\/10.5281\/ZENODO.3364087. URL:https:\/\/zenodo.org\/record\/3364087#.XWlBZZNKjUI."},{"key":"10.1016\/j.radonc.2020.01.017_b0165","doi-asserted-by":"crossref","unstructured":"Gauthier J, Wu QV, Gooley TA. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians. Bone Marrow Transplantation.https:\/\/doi.org\/10.1038\/s41409-019-0679-x.","DOI":"10.1038\/s41409-019-0679-x"},{"key":"10.1016\/j.radonc.2020.01.017_b0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2007.03.023","article-title":"Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy","volume":"69","author":"Grills","year":"2007","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2020.01.017_b0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1748-717X-9-210","article-title":"Stereotactic Body Radiation Therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review","volume":"9","author":"Amini","year":"2014","journal-title":"Rad Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2016.07.013","article-title":"Immune modulation by hypofractionated stereotactic radiation therapy: therapeutic implications","volume":"120","author":"Popp","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.01.017_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-5002(99)00019-7","article-title":"Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients","volume":"24","author":"Martel","year":"1999","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.radonc.2020.01.017_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2013.09.006","article-title":"Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort","volume":"109","author":"Sold\u00e0","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020300360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020300360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:10:01Z","timestamp":1759122601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020300360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":38,"alternative-id":["S0167814020300360"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.01.017","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}